131 related articles for article (PubMed ID: 27917722)
21. Survival impact of treatment options for papillary microcarcinoma of the thyroid.
Lin HW; Bhattacharyya N
Laryngoscope; 2009 Oct; 119(10):1983-7. PubMed ID: 19655332
[TBL] [Abstract][Full Text] [Related]
22. Pan-cancer clinical and molecular analysis of racial disparities.
Lara OD; Wang Y; Asare A; Xu T; Chiu HS; Liu Y; Hu W; Sumazin P; Uppal S; Zhang L; Rauh-Hain JA; Sood AK
Cancer; 2020 Feb; 126(4):800-807. PubMed ID: 31730714
[TBL] [Abstract][Full Text] [Related]
23. Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer.
Roche AM; Fedewa SA; Shi LL; Chen AY
Cancer; 2018 Apr; 124(8):1780-1790. PubMed ID: 29409119
[TBL] [Abstract][Full Text] [Related]
24. Surgery for papillary thyroid carcinoma: is lobectomy enough?
Mendelsohn AH; Elashoff DA; Abemayor E; St John MA
Arch Otolaryngol Head Neck Surg; 2010 Nov; 136(11):1055-61. PubMed ID: 21079156
[TBL] [Abstract][Full Text] [Related]
25. Extent of surgery for low-risk thyroid cancer in the elderly: Equipoise in survival but not in short-term outcomes.
Zambeli-Ljepović A; Wang F; Dinan MA; Hyslop T; Stang MT; Roman SA; Sosa JA; Scheri RP
Surgery; 2019 Nov; 166(5):895-900. PubMed ID: 31288935
[TBL] [Abstract][Full Text] [Related]
26. Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer.
Barney BM; Hitchcock YJ; Sharma P; Shrieve DC; Tward JD
Head Neck; 2011 May; 33(5):645-9. PubMed ID: 20687168
[TBL] [Abstract][Full Text] [Related]
27. Racial disparities in esophageal cancer treatment and outcomes.
Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; McGinn TG; Wisnivesky JP
Ann Surg Oncol; 2008 Mar; 15(3):881-8. PubMed ID: 17987341
[TBL] [Abstract][Full Text] [Related]
28. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005.
Enewold L; Zhu K; Ron E; Marrogi AJ; Stojadinovic A; Peoples GE; Devesa SS
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):784-91. PubMed ID: 19240234
[TBL] [Abstract][Full Text] [Related]
29. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
Lediju O; Ikuemonisan J; Salami SS; Adejoro O
J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
[TBL] [Abstract][Full Text] [Related]
30. Disparity in the use of adjuvant radioactive iodine ablation among high-risk papillary thyroid cancer patients.
Moten AS; Zhao H; Intenzo CM; Willis AI
Eur J Surg Oncol; 2019 Nov; 45(11):2090-2095. PubMed ID: 31253543
[TBL] [Abstract][Full Text] [Related]
31. Incidental thyroid papillary microcarcinoma: survival and follow-up.
Gorostis S; Raguin T; Schneegans O; Takeda C; Debry C; Dupret-Bories A
Laryngoscope; 2019 Jul; 129(7):1722-1726. PubMed ID: 30618067
[TBL] [Abstract][Full Text] [Related]
32. Association of Socioeconomic Status and Race/Ethnicity With Treatment and Survival in Patients With Medullary Thyroid Cancer.
Roche AM; Fedewa SA; Chen AY
JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):763-71. PubMed ID: 27254481
[TBL] [Abstract][Full Text] [Related]
33. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
[TBL] [Abstract][Full Text] [Related]
34. Papillary thyroid microcarcinoma: an over-treated malignancy?
Wang TS; Goffredo P; Sosa JA; Roman SA
World J Surg; 2014 Sep; 38(9):2297-303. PubMed ID: 24791670
[TBL] [Abstract][Full Text] [Related]
35. Regional and racial disparities in breast cancer-specific mortality.
Grann V; Troxel AB; Zojwalla N; Hershman D; Glied SA; Jacobson JS
Soc Sci Med; 2006 Jan; 62(2):337-47. PubMed ID: 16051406
[TBL] [Abstract][Full Text] [Related]
36. The ongoing racial disparities in melanoma: An analysis of the Surveillance, Epidemiology, and End Results database (1975-2016).
Qian Y; Johannet P; Sawyers A; Yu J; Osman I; Zhong J
J Am Acad Dermatol; 2021 Jun; 84(6):1585-1593. PubMed ID: 32861710
[TBL] [Abstract][Full Text] [Related]
37. The Role of Stage at Diagnosis in Colorectal Cancer Black-White Survival Disparities: A Counterfactual Causal Inference Approach.
Valeri L; Chen JT; Garcia-Albeniz X; Krieger N; VanderWeele TJ; Coull BA
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):83-9. PubMed ID: 26503034
[TBL] [Abstract][Full Text] [Related]
38. Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period.
Aizer AA; Wilhite TJ; Chen MH; Graham PL; Choueiri TK; Hoffman KE; Martin NE; Trinh QD; Hu JC; Nguyen PL
Cancer; 2014 May; 120(10):1532-9. PubMed ID: 24863392
[TBL] [Abstract][Full Text] [Related]
39. Racial Disparities in Differentiated Thyroid Cancer: Have We Bridged the Gap?
Shah SA; Adam MA; Thomas SM; Scheri RP; Stang MT; Sosa JA; Roman SA
Thyroid; 2017 Jun; 27(6):762-772. PubMed ID: 28294040
[TBL] [Abstract][Full Text] [Related]
40. Racial disparities in oropharyngeal cancer survival.
Megwalu UC; Ma Y
Oral Oncol; 2017 Feb; 65():33-37. PubMed ID: 28109465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
